Journal of Mass Spectrometry · 1995 · 10 citations · 25 references
Life SciencesBiochemistryMolecular BiologyChromatographic AnalysisProtein BiochemistryProteomicsChromatographyPeptide AnalysisPeptide Hormone BiochemistryProtein SeparationProteolytic EnzymesProteolytic ProcessingDigestionMass Spectrometric IdentificationMass Spectrometry ProteomicsMethionine OxidationMolecular Mass DeterminationPeptide MappingProteolytic Digestion AnalysisProteolytic Processing Analysis
Abstract An N ‐terminal proteolytic processing product of chromogranin A was obtained from bovine chromaffin granules using two steps of C 18 solid‐phase extraction and reversed‐phase high‐performance liquid chromatography. Electrospray mass spectrometry revealed a protein with a molecular mass of 8632.0 for the fraction showing immunoreactivity against the N ‐terminus of chromogranin A, which differed by 48 u from that of the N ‐terminal processing product, vasostatin I (CGA 1−76 ). Derivatization with mercaptoethanol showed that the peptide had an intact SS bridge, which is a key structural feature of vasostatin I. Peptide mapping experiments involving reduction/alkylation with vinylpyridine and trypsin digestion were consistent with oxidation of the three methionine residues of vasostatin I to their sulphoxide forms. The oxidation of the methionine residues was found to occur during the C 18 solid‐phase extraction procedure. The use of freshly prepared Tris–HCl buffer and eluents and flushing the buffer and eluents with nitrogen were shown to result in the isolation of the non‐oxidized form of vasostatin I.
25
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion
Kazuhiko Tatemoto, S. Efendić, Viktor Mutt et al. · Nature · 1986 · 687 citations
ULRICHM. BENEDUM, Patrick A. Baeuerle, David Konecki et al. · The EMBO Journal · 1986 · 253 citations · Full text